S. 229, titled the "Drug-price Transparency for Consumers Act of 2025," aims to require that direct-to-consumer advertisements for prescription drugs and biological products disclose pricing information. The bill seeks to make consumers aware of the wholesale acquisition cost...
Simple Explanation
The Drug-price Transparency for Consumers Act of 2025 wants to make sure that when you see ads for medicine on TV, they tell you how much the medicine costs, so you know what to expect before you buy it. This helps people (and their families) understand medicine prices better, as long as the cost is over a certain small amount.